These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15478378)

  • 21. Control of IgE and selective T(H)1 and T(H)2 cytokines by PG102 isolated from Actinidia arguta.
    Park EJ; Kim B; Eo H; Park K; Kim Y; Lee HJ; Son M; Chang YS; Cho SH; Kim S; Jin M
    J Allergy Clin Immunol; 2005 Nov; 116(5):1151-7. PubMed ID: 16275390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription.
    Usui T; Preiss JC; Kanno Y; Yao ZJ; Bream JH; O'Shea JJ; Strober W
    J Exp Med; 2006 Mar; 203(3):755-66. PubMed ID: 16520391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities.
    Lametschwandtner G; Biedermann T; Schwärzler C; Günther C; Kund J; Fassl S; Hinteregger S; Carballido-Perrig N; Szabo SJ; Glimcher LH; Carballido JM
    J Allergy Clin Immunol; 2004 May; 113(5):987-94. PubMed ID: 15131585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic targeted therapy in allergic asthma.
    Bice JB; Leechawengwongs E; Montanaro A
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):108-15. PubMed ID: 24468249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Imbalanced T cell-specific transcription factors T-bet and GATA-3 contributes to type 2 T helper cell polarization in asthmatic patients].
    Liu CT; Wang G; Luo FM; Wang ZL; Liu R; Wang CL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):398-402. PubMed ID: 15256090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulators for allergic respiratory disorders.
    Casale TB; Stokes JR
    J Allergy Clin Immunol; 2008 Feb; 121(2):288-96; quiz 297-8. PubMed ID: 18269921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
    Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
    Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attainments in atop: special aspects of allergy and IgE.
    Milgrom H
    Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoregulation in allergy: the potential of anti-IgE antibodies of IL-4 antagonists for the treatment of allergic diseases.
    Heusser C
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):283-9; discussion 289-91. PubMed ID: 7873064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood asthma as an allergic disease: rationale for the development of future treatment.
    Tang ML; Powell CV
    Eur J Pediatr; 2001 Dec; 160(12):696-704. PubMed ID: 11795676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
    Oda N; Minoguchi K; Tanaka A; Yokoe T; Minoguchi H; Matsuo H; Nakashima M; Tasaki T; Adachi M
    Clin Exp Allergy; 2002 Dec; 32(12):1782-6. PubMed ID: 12653172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.
    Liu N; Ohnishi N; Ni L; Akira S; Bacon KB
    Nat Immunol; 2003 Jul; 4(7):687-93. PubMed ID: 12766768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quercetin regulates Th1/Th2 balance in a murine model of asthma.
    Park HJ; Lee CM; Jung ID; Lee JS; Jeong YI; Chang JH; Chun SH; Kim MJ; Choi IW; Ahn SC; Shin YK; Yeom SR; Park YM
    Int Immunopharmacol; 2009 Mar; 9(3):261-7. PubMed ID: 19061976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.
    Shimizu Y; Dobashi K; Fueki N; Fueki M; Okada T; Tomioka S; Makino S; Mori M
    J Biol Regul Homeost Agents; 2011; 25(2):177-86. PubMed ID: 21880206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses to Nippostrongylus brasiliensis and tuberculin protein in GATA-3-transgenic mice.
    Ozawa H; Tamauchi H; Ito M; Terashima M; Inoue M; Hozumi K; Habu S; Watanabe N
    Immunol Lett; 2005 Jul; 99(2):228-35. PubMed ID: 16009272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
    Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
    Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
    Wang HH; Lin CY
    Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stemucronatoside L, a pregnane glycoside from the roots of Stephanotis mucronata, inhibits Th1/Th2 immune responses in vitro.
    Chen FY; Ye YP; Sun HX; Li XY; Shi H
    Chem Biodivers; 2009 Jun; 6(6):916-23. PubMed ID: 19551733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.